GUANGZHOU BAIYUNSHAN PHARMACEUTICAL revenue for the last year amounted to 83.08 B HKD, the most of which — 58.45 B HKD — came from its highest performing source at the moment, Great Commerce, the year earlier bringing 57.31 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought GUANGZHOU BAIYUNSHAN PHARMACEUTICAL 83.06 B HKD, and the year before that — 82.29 B HKD.